Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro pen contains four weekly doses, so a single pen covers one month of treatment. A 3-pack bundle — three pens ordered together — covers roughly three months. That's the simple answer. As a prescription-only medicine, Mounjaro requires a clinical assessment before any supply; a prescriber, not a checkout process, decides whether it is appropriate for you and at which dose. What follows explains how multi-pen supply works, what a bundle includes, and how our clinician-led service handles repeat ordering safely.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) is supplied in pre-filled KwikPens, each loaded with four doses of a single strength. You inject once a week, so one pen runs for exactly four weeks. A 3-pack bundle is three pens of the same strength, giving you a continuous 12-week supply without interruption, useful if you are stable on a dose and want fewer individual orders to think about.
UK strengths run from 2.5 mg up to 15 mg in six steps. A 3-pack must be prescribed at a consistent strength, which is why this kind of order suits patients who are settled at their current dose rather than those mid-titration. If your prescriber expects to move you to a higher strength within those 12 weeks, three pens of the current dose would leave you with surplus stock you cannot use at the new level.
For a detailed overview of how tirzepatide works and its licensed indications, the tirzepatide information page covers the mechanism and eligibility criteria. The NHS also publishes patient-level guidance on tirzepatide covering storage, what to do with unused pens, and the injection process, at nhs.uk/medicines/tirzepatide.
Yes, there is no rule capping a single prescription at one pen. A prescriber can issue a prescription covering multiple pens where it is clinically appropriate to do so. The key word is appropriate. Before any supply, including a multi-pen order, a clinician must be satisfied that the strength is correct, that you have tolerated previous doses without significant problems, and that no new contraindications have arisen.
At nume, every order (first or repeat) is read by a real prescriber the same day it arrives. A three-month bundle is not waved through automatically; the prescriber reviews your most recent weight, any side effects you have reported, and whether the dose you are requesting matches the clinical picture. That review happens before dispensing, not after. If something in the answers gives them pause, they will contact you rather than simply process the order.
People sometimes time a larger order around a payday, a long holiday, or the run-up to Christmas when they want fewer things to organise, that is a perfectly sensible reason to ask about a 3-pack. The clinical review still applies regardless of timing. If you want to understand what a full assessment involves, our frequently asked questions page covers the consultation process in detail.
This is the most common practical question about multi-pen orders, and it deserves a straight answer. Tirzepatide treatment typically starts at 2.5 mg to allow your system to adjust, then moves up through the dose steps (5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) roughly every four weeks, guided by tolerability and clinical judgement.
If you are still climbing that schedule, a 3-pack of one strength may not match what your prescriber plans for you over the same period. Three months into active titration, you might expect to be two or even three steps higher than your starting point. Ordering three pens of a strength you will only use for one month wastes money and creates storage complications, Mounjaro must be kept refrigerated at 2–8°C, and unused pens do not transfer easily to another person.
A 3-pack genuinely makes sense once you and your prescriber agree that you have reached your maintenance or highest-tolerated dose. At that point, a consistent supply of the same pen reduces the admin burden without creating clinical risk. Our Mounjaro bundle information gives more context on how bundle ordering is structured at nume. For a broader look at how weight-loss treatment options compare and what to consider when choosing between them, that page is a useful starting point.
It is worth understanding what you are paying for with any Mounjaro supply. A legitimate prescription for a prescription-only medicine includes a clinical assessment, the prescribing decision itself, and the dispensing from a pharmacy regulated by the GPhC. When those elements are separated out (or absent) the price may look lower, but the risk profile is very different.
Eli Lilly raised the UK list price of Mounjaro from 1 September 2025, with the highest-dose pen's list price rising from around £122 to around £330. Private market prices since then have ranged roughly £149–£375 per pen by dose and provider, as widely reported. For context on what typical private treatment costs and what those figures include, the Mounjaro bundle deals page sets this out clearly. The short version: at nume, one transparent price covers the consultation, the prescription, the medicine, and free next-working-day tracked delivery, with no subscription and no automatic renewal.
For a prescription medicine, the right question is not which listing is cheapest but which route gives you genuine clinical oversight and verified supply. The NICE appraisal of tirzepatide (TA1026) sets out the evidence base and eligibility criteria that underpin responsible prescribing. If you are ready to discuss whether a 3-pack order fits your treatment plan, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.